Open AccessP609: CLINICOBIOLOGICAL CHARACTERISTICS AND TREATMENT EFFICACY OF NOVEL AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGLV3‐21R110
Author(s) -
Hengeveld P.,
Ertem Y. E.,
Dubois J.,
Mellink C.,
KevieKersemaekers A.M.,
Evers L.,
Heezen K.,
Kolijn P. M.,
Mook O.,
Motazacker M. M.,
Nasserinejad K.,
Kersting S.,
Westerweel P.,
Niemann C.,
Kater A.,
Langerak A.,
Levin M.D.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845324.19039.8a
Subject(s) - chronic lymphocytic leukemia , medicine , fludarabine , ibrutinib , context (archaeology) , oncology , ighv@ , chemoimmunotherapy , somatic hypermutation , immunology , leukemia , b cell , antibody , biology , chemotherapy , cyclophosphamide , paleontology